| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.4K | $2.54M | - | |
| CFO | 215.4K | $1.79M | - | |
| Dir | 119.9K | $998.4K | - | |
| VP | 104.1K | $867.2K | - | |
| Dir | 89.0K | $741.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2018 | El-Hibri Fuad | Chairman | Sell | 36,318 | $55.98 | $2,033,109.26 | -1.2% | |
| Jul 12, 2018 | El-Hibri Fuad | Chairman | Sell | 15,000 | $54.50 | $817,552.00 | -0.5% | |
| Jul 9, 2018 | El-Hibri Fuad | Chairman | Sell | 15,000 | $53.61 | $804,150.00 | -1.0% | |
| Jun 11, 2018 | Joulwan George A | Director | Sell | 5,000 | $52.89 | $264,447.50 | -14.2% | |
| Jun 6, 2018 | Zoon Kathryn C62 | Director | Sell | 376 | $52.81 | $19,856.56 | -1.6% | |
| Jun 6, 2018 | Richard Ronald | Director | Sell | 7,342 | $53.00 | $389,126.00 | -25.9% | |
| Jun 5, 2018 | Abdun-Nabi Daniel | Chief Executive Officer | Sell | 15,785 | $52.11 | $822,614.75 | -7.4% | |
| Jun 5, 2018 | Hauer Jerome M | Director | Sell | 8,375 | $52.16 | $436,876.01 | -40.0% | |
| May 24, 2018 | Zoon Kathryn C62 | Director | Sell | 1,377 | $51.15 | $70,433.55 | -5.6% | |
| Apr 17, 2018 | Richard Ronald | Director | Sale+OE | 7,893 | $55.00 | $434,115.00 | -25.2% |